Clinical Trial Update: A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical recombinant human vascular endothelial growth factor for healing diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Topical recombinant human vascular endothelial growth factor (recombinant human vascular endothelial growth factor)

Snippet

Sponsor: Genentech, Inc. | Conditions: Foot Ulcer, Diabetic | Phase 2 | Status: COMPLETED